Why isn't tirzepatide working for me?

Step 1: Understand where you are in the treatment timeline

The single most common reason people feel tirzepatide isn't working is that they're measuring too early. The 2.5 mg starting pen exists to let your body adjust to the medicine, not to produce rapid weight loss. Most people notice the first real shift in appetite and weight as the dose increases beyond 5 mg, and the Mounjaro prescribing schedule is built around four-weekly titration steps for exactly this reason.

A question our prescribers hear most weeks is some version of: "I've been on it for a month and nothing's happened." Almost always, that person is still on the starter dose. Weight change in the first four to eight weeks is often minimal, and that's expected. The NHS tirzepatide patient information confirms that the dose is titrated over time to find the level that works for you, the NHS tirzepatide guidance is worth reading if you haven't already. Give the treatment the timeline it was designed around before concluding it isn't working.

If you're several months in and on a higher dose with genuinely no change, that's a different conversation, one for your prescriber, who can look at the full picture rather than a single number on the scales.

Step 2: Check whether lifestyle factors are counteracting the medicine

Tirzepatide reduces appetite and slows how quickly food leaves your stomach. It doesn't override every calorie you consume, and it doesn't work independently of how you eat, move and sleep. People who continue eating very calorie-dense foods in large quantities (often because habit or emotional drivers persist even when hunger is reduced) tend to see slower results than the trial populations, who were enrolled in structured behavioural programmes alongside their medication.

Alcohol is worth mentioning separately. It's calorie-dense, it can blunt the appetite-suppressing effect for several hours, and it interferes with sleep quality, which is itself linked to appetite regulation. You don't need to stop completely, but it's worth being honest about the total picture.

Sleep deprivation and high stress both raise cortisol, which drives hunger signals independently of GLP-1 and GIP pathways. Tirzepatide works with your biology, not against every part of it at once. If diet and lifestyle factors haven't been reviewed recently, that's usually the most productive place to start. NHS Better Health's lose weight guidance has practical, non-prescriptive starting points.

Step 3: Rule out practical or pharmacological reasons

Several factors can reduce how well tirzepatide is absorbed or how effectively it suppresses appetite, even when the dose looks right on paper.

Injection technique matters more than most people expect. If the pen isn't used correctly (wrong angle, wrong site, not waiting for the full injection to complete) some of the dose can be lost. Rotating between the abdomen, thigh and upper arm, and making sure the site is clean and pinched correctly, helps. The Patient Information Leaflet that comes with the pen covers this step by step, and it's worth re-reading if you're not certain.

Other medicines can interact. Some cause weight gain that partially offsets tirzepatide's effect (certain antidepressants, corticosteroids, antipsychotics, and some diabetes medicines are the common examples). Others may affect absorption. If your other medicines have changed recently and your weight loss has stalled, bring that list to your prescriber. You can review what might cause tirzepatide to stop working mid-course for a fuller breakdown of pharmacological reasons.

Thyroid function is also worth checking if you haven't had it tested recently. Undiagnosed or undertreated hypothyroidism slows metabolism and can make weight loss resistant regardless of the medicine. That's a simple blood test your GP can arrange.

Step 4: Speak to a prescriber before making any changes

If you've worked through the above and things still aren't moving, the right next step is a proper clinical conversation, not increasing your own dose, not stopping the medicine without guidance, and not switching based on something you've read online. NICE's appraisal of tirzepatide notes that if less than 5% weight loss is achieved after six months at the highest tolerated dose, the clinical team should review whether continuing is appropriate; that review should be with a prescriber who knows your full history, not a self-assessment based on a target from a forum.

For context on how tirzepatide's real-world range of results compares with the trial data, see our page on what happens when Mounjaro stops working. And if you're weighing up what private treatment costs against what you're getting from it, that's a fair question to raise with a prescriber too. At nume, a real clinician reviews every consultation the same day, no automation involved. If you'd like that review, speak to our prescribers to get started.